Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database
5-year overall survival rate 91.9% when disease-free interval exceeded 24 months.
»
06/04/21
Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer
Cardiac irradiation in RT of LA-NSCLC can be reduced substantially.
»
06/03/21
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization
Downregulation of PLA2G3 in OVCAR8 and 5 cells inhibited LD biogenesis.
»
06/03/21
IFI35 is involved in the regulation of the radiosensitivity of colorectal cancer cells
Upregulation of IFI35 inhibited cell proliferation and colony formation.
»
06/03/21
Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines
NCCN guidelines identify 13.2% of women.
»
06/03/21
Circulating immune cell populations related to primary breast cancer, surgical removal, and radiotherapy revealed by flow cytometry analysis
Changes in blood leukocytes associated with primary BC.
»
06/05/21
Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
Four histone modification-related genes identified.
»
06/05/21
Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)
3-year OS rate in NACTRH and CRT groups were 97 and 90% respectively.
»
06/05/21
Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours
Identified known and novel target genes regulated by mutant p53.
»
06/05/21
Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation
None developed late toxicity beyond 90 days of follow-up.
»
06/07/21
< Prev
Next >